Construction and characterization of a selectable multidrug resistance-glucocerebrosidase fusion gene

Cytokines and Molecular Therapy

Volumn 2, Issue 1, 1996, Pages 47-57

  Aran, Josep M ^a   Germann, Ursula A ^b   Gottesman, Michael M ^a   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

Author keywords

Cryptic splicing; Gene fusion; Glucocerebrosidase; Lysosomes; P glycoprotein

Indexed keywords

GLUCOSYLCERAMIDASE; GLYCOPROTEIN P; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; FIBROBLAST; GENE FUSION; GENETIC SELECTION; LONG TERMINAL REPEAT; LYSOSOME; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RETROVIRUS; RNA TRANSCRIPTION;

AMINO ACID SEQUENCE; ANIMALS; ARTIFICIAL GENE FUSION; BASE SEQUENCE; CATHEPSINS; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; GENES, MDR; GLUCOSYLCERAMIDASE; HUMANS; MICE; P-GLYCOPROTEIN; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0029984334     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gottesman MM, Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Anmi Rev Biochem (1993) 62: 385-427.
2. Gottesman MM, Pastan I, The multidrug resistance (MDR1) gene as a selectable marker in gene therapy. In: Human gene transfer (ed O Cohen-Haguenauer, M Boiron) Vol 219: 185-91. Colloque INSERM/fohn Libbey Eurotext, 1991.
3. Sorrentino BP, Brandt SJ, Bodine D et al, Retroviral transfer of the human MDR1 gene permits selection of drug resistant bone marrow cells in vivo. Science . (1992) 257:99-103.
4. Podda S, Ward M, Himelstein A et al, Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA (1992) 89: 9676-80.
5. Emerman M, Temin HH, Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 39: 45967.
6. Emerman M, Temin HH, Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol CellBiol (1986) 6: 792-800.
7. Olsen JC, Johnson LG, Wong-Sun ML et al, Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: effect of selectable marker sequences on long-term expression. Nucleic Acids Res (1993) 21: 663-9.
8. Aran JM, Gottesman MM, Pastan I, Drug-selected coexpression of human glucocerebrosidase and Pglycoprotein using a bicistronic vector. Proc Natl Acad Sd USA (1994) 91: 3176-80.
9. Kaufman RJ, Davies MV, Wasley LC, Michnick D, Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res (1991) 19: 4485-90.
10. Morgan RA, Couture L, Elroy-Stein O et al, Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res (1992) 20: 1293-9.
11. Dirks W, Wirth M, Hauser H, Dicistronic transcription units for gene expression in mammalian cells. Gene (1993) 129: 247-9.
12. Germann UA, Gottesman MM, Pastan I, Expression of a multidrug resistance-adenosine deaminase fusion gene. J Biol Client (1989) 264: 7418-24.
13. Germann UA, Chin K-V, Pastan I, Gottesman MM, Retroviral transfer of a chimeric multidrug resistanceadenosine deaminase gene. FASEBJ (1990) 4: 1501-7.
14. Barranger JA, Ginns El, Glucosylceramide lipidoses: Gaucher disease. In: The metabolic basis of inherited disease (ed CR Scriver, AL Beaudet, WS Sly, D Valle) 1677-98. McGraw-Hill, New York, 1989.
15. Grabowski GA, Gatt S, Horowitz M, Acid β-glucosidase: enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol (1990) 25: 385-414.
16. Barton NW, Brady RO, Dambrosia JM et al, Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher disease. NEnglJMed (1991) 324: 1464-70.
17. Beutler E, Gaucher disease: new molecular approaches to diagnosis and treatment. Science (1992) 256: 794-9.
18. Pastan I, Gottesman MM, Ueda'K et al, A retrovirus carrying a MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA (1988) 85: 4486-90.
19. Choudary PV, Tsuji S, Martin BM et al, The molecular biology of Gaucher disease and the potential for gene therapy. Cold Spring Harbor Sytnp Quant Biol (1986) 51(2): 1047-52.
20. Danos O, Mulligan RC, Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA (1988) 85: 6460-4.
21. Chomczynski P, Sacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem (1987) 162: 156-9.
22. Ginns El, Brady RO, Pirrucello S et al, Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Proc Natl Acad Sci USA (1982) 79: 5607-10.
23. Kartner N, Evernden-Porelle D, Bradley G, Ling V, Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature (1985) 316: 820-3.
24. Gottesman MM, Cabrai F, Purification and characterization of a transformation-dependent protein secreted by cultured murine fibroblasts. Biochemistry (1981) 20:1659-65.
25. Sorge J, West C, Kühl W et al, The human glucocerebrosidase gene has two functional ATG initiator codons. Am J Hum Genet (1987) 41: 1016-24.
26. Watson ME, Compilation of published signal sequences. Nucleic Acids Res (1984) 12: 5145-64.
27. Walter P, Gilmore R, Blobel G, Protein translocation across the endoplasmic reticulum. Cell (1984) 38: 5-8.
28. Rosenfeld MG, Kreibich G, Popow D et al, Biosynthesis of lysosomal hydrolases: their synthesis in bound polysomes and the role of co- and posttranslational proessing in determining their subcellular distribution. J Cell Bid (1982) 93: 135-43.
29. Hamada H, Tsuruo T, Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl AcadSci USA (1986) 83: 7785-9.
30. Jonsson LMV, Murray GJ, Sorrell SH et al, Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. Eur J Biochem (1987) 164: 171-9.
31. Gal S, Willingham MC, Gottesman MM, Processing and lysosomal localization of a glycoprotein whose secretion is transformation stimulated. J Cell Biol (1983) 100:535-44.
32. Erickson AH, Ginns EI, Barranger JA, Biosynthesis of the lysosomal enzyme glucocerebrosidase. J Biol Chem (1985) 260: 14319-24.
33. Sorge J, West C, Westwood B, Beuüer E, Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc NatlAcad Sci USA (1985) 82: 7289-93.
34. Aerts JMFG, Donker-Koopman WE, Laar CV et al, Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts. EnrJBiochem (1987) 163: 583-9.
35. Shimabuku AM, Nishimoto T, Ueda K, Komano T, P-glycoprotein. ATP hydrolysis by the N-terminal nucleotide binding domain. J Biol Chem (1992) 267: 4308-11.
36. Currier SJ, Ueda K, Willingham MC et al, Deletion and insertion mutants of the multidrug transporter. J Biol Chem (1989) 264: 14376-81.
37. Shimabuku AM, Saeki T, Ueda K, Komano T, Productin of a site specifically cleavable P-glycoprotein-β-galactosidase fusion protein. Agric Biol Chem (1991) 55: 1075-80.
38. Sorrentino BP, McDonagh KT, Woods D, Orlic D, Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood (1995) 86: 491-501.
39. Caceres JE, Stamm S, Helfman DM, Drainer AR, Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science (1994) 265: 1706-9.